IL6 and COVID-19: Important data also show that the increase in IL-6 in COVID-19 may be associated with poor prognosis, admission to the Intensive Care Unit, Acute Respiratory Distress Syndrome, respiratory failure, shock, multiple organ dysfunction, and risk of death, being a good marker to monitor these patients [25,26].